Yasuhiro Oki
Impact in
- Pathology and Forensic Medicine top 0.2%
- Lymphoma Diagnosis and Treatment
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 145
- Oncology 81
- Viral-associated cancers and disorders 49
- Co-authors
- Jean‐Pierre J. Issa (19 shared papers)Anas Younes (44 shared papers)Hagop M. Kantarjian (10 shared papers)Jaroslav Jelı́nek (8 shared papers)Michelle A. Fanale (68 shared papers)Sattva S. Neelapu (52 shared papers)Luis Fayad (54 shared papers)Xuelin Huang (5 shared papers)
- Journals
- Blood (56 papers)Journal of Clinical Oncology (21 papers)British Journal of Haematology (15 papers)International Journal of Radiation Oncology*Biology*Physics (10 papers)Cancer (6 papers)
- Partner nations
- United StatesJapanAustralia
In The Last Decade
Yasuhiro Oki
198 papers receiving 6.2k citations
Yasuhiro Oki's Hit Papers
Peers
Comparison fields: 5 of 121
- Pathology and Forensic Medicine 3.1k
- Genetics 1.7k
- Hematology 1.3k
- Oncology 2.3k
- Dermatology 561
Countries citing papers authored by Yasuhiro Oki
This map shows the geographic impact of Yasuhiro Oki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuhiro Oki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuhiro Oki more than expected).
Fields of papers citing papers by Yasuhiro Oki
This network shows the impact of papers produced by Yasuhiro Oki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuhiro Oki. The network helps show where Yasuhiro Oki may publish in the future.
Co-authors
The 25 scholars most cited alongside Yasuhiro Oki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 207 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia Hit paper breakdown → | 2006 | 515 |
| 2 | 2009 | 261 | |
| 3 | 2005 | 260 | |
| 4 | 2014 | 242 | |
| 5 | 2015 | 207 | |
| 6 | 2017 | 204 | |
| 7 | 2014 | 186 | |
| 8 | 2017 | 183 | |
| 9 | 2016 | 156 | |
| 10 | 2011 | 156 | |
| 11 | 2006 | 125 | |
| 12 | 2009 | 108 | |
| 13 | 2017 | 102 | |
| 14 | 2007 | 99 | |
| 15 | 2019 | 90 | |
| 16 | 2008 | 89 | |
| 17 | 2013 | 85 | |
| 18 | 2006 | 80 | |
| 19 | 2011 | 74 | |
| 20 | 2006 | 72 |
About Yasuhiro Oki
Yasuhiro Oki is a scholar working on Pathology and Forensic Medicine, Oncology, Genetics, Molecular Biology and Neurology, having authored 207 papers that have together received 6.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (145 papers), Chronic Lymphocytic Leukemia Research (50 papers), Viral-associated cancers and disorders (49 papers), CNS Lymphoma Diagnosis and Treatment (38 papers), Histone Deacetylase Inhibitors Research (24 papers), Cutaneous lymphoproliferative disorders research (20 papers), Acute Myeloid Leukemia Research (16 papers) and Lung Cancer Treatments and Mutations (15 papers). The work is most often cited by research in Pathology and Forensic Medicine (3.1k citations), Genetics (1.7k citations), Hematology (1.3k citations), Oncology (2.3k citations) and Dermatology (561 citations). Yasuhiro Oki has collaborated with scholars based in United States, Japan and Australia. Frequent co-authors include Jean‐Pierre J. Issa, Anas Younes, Hagop M. Kantarjian, Jaroslav Jelı́nek, Michelle A. Fanale, Sattva S. Neelapu, Luis Fayad, Xuelin Huang, Carlos E. Bueso‐Ramos and Steven M. Horwitz. Their work appears in journals such as Blood, Journal of Clinical Oncology, British Journal of Haematology, International Journal of Radiation Oncology*Biology*Physics and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.